Hepatoprotection via the IL-6/Stat3 pathway

Journal of Clinical Investigation

Volumn 112, Issue 7, 2003, Pages 978-980

  Taub, Rebecca ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENOVIRUS VECTOR; ANTIOXIDANT; CASPASE INHIBITOR; CYTOKINE; DNA; FAS LIGAND; FLICE INHIBITORY PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; REDOX EFFECTOR FACTOR 1; STAT3 PROTEIN; TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; FAS ANTIGEN; STAT3 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL MODEL; APOPTOSIS; CELL SURVIVAL; DNA BINDING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE DELETION; GENETIC TRANSCRIPTION; IMMUNE SYSTEM; LIVER FAILURE; LIVER INJURY; LIVER PROTECTION; LIVER REGENERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL PROTECTION; LIVER; NOTE; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CELL SURVIVAL; CYTOPROTECTION; DNA-BINDING PROTEINS; INTERLEUKIN-6; LIVER; LIVER REGENERATION; MICE; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 85047689502     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI19974     Document Type: Review

References (22)

1. Kaplowitz, N.K., and DeLeve, L.D. 2003. Drug-induced liver disease. Marcel Dekker Inc. New York, New York, USA. 773 pp.
2. Matsumura, H., et al. 2000. Necrotic death pathway in Fas receptor signaling. J. Cell Biol. 151:1247-1256.
3. Pinkoski, M.J., Brunner, T., Green, D.R., and Lin, T. 2000. Fas and Fas ligand in gut and liver. Am. J. Physiol. Gastrointest. Liver Physiol. 278:G354-G366.
4. Kanzler, S., and Galle, P.R. 2000. Apoptosis and the liver. Semin. Cancer Biol. 10:173-184.
5. Suzuki, Y., Ono, Y., and Hirabayashi, Y. 1998. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett. 425:209-212.
6. Jayanthi, S., Ordonez, S., McCoy, M.T., and Cader, J.L. 1999. Dual mechanism of Fas-induced cell death in neuroglioma cells: a role for reactive oxygen species. Brain Res. Mol. Brain Res. 72:158-165.
7. Taub, R., Greenbaum, L.E., and Peng, Y. 1999. Transcriptional regulatory signals define cytokine-dependent and independent pathways in liver regeneration. Semin. Liver Dis. 19:117-127.
8. Kovalovich, K., et al. 2000. Increased toxin-induced liver injury and fibrosis in interleukin-6 deficient mice. Hepatology. 31:149-159.
9. Kovalovich, K., et al. 2001. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J. Biol. Chem. 276:26605-26613.
10. Galun, E., Zeira, E., Pappo, O., Peters, M., and Rose-John, S. 2000. Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB J. 14:1979-1987.
11. Ozaki, M., Haga, S., Zhang, H., Irani, K., and Suzuki, S. 2003. Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated anti-apoptotic signaling: role of PI3-K and Akt kinase upon rac1. Cell Death Differ. 10:508-515.
12. Haga, S., et al. 2003. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J. Clin. Invest. 112:989-998. doi:10.1172/JCI200317970.
13. Debonera, F., et al. 2001. Activation of interleukin-6/STAT3 and liver regeneration following transplantation. J. Surg. Res. 96:289-295.
14. Li, W., Liang, X., Kellendonk, C., Poli, V., and Taub, R. 2002. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J. Biol. Chem. 277:28411-28417.
15. Levy, D.E., and Lee, C.-K. 2002. What does Stat3 do? J. Clin. Invest. 109:1143-1148. doi:10.1172/ JCI200215650.
16. Hirano, T., Ishihara, K., and Hibi, M. 2000. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 19:2548-2556
17. Leu, J.I., Crissey, M.A., Leu, J.P., Ciliberto, G., and Taub, R. 2001. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol. Cell. Biol. 21:414-424.
18. Ozaki, M., Suzuki, S., and Irani, K. 2002. Redox factor-1/APE suppresses oxidative stress by inhibiting the rac1 GTPase. FASEB J. 16:889-890.
19. Ozaki, M., et al. 2000. Inhibition of the Rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo. FASEB J. 14:418-429.
20. Grosch, S., Fritz, G., and Kaina, B. 1998. Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation. Cancer Res. 58:4410-4416.
21. Nakamura, H., Nakamura, K., and Yodoi, J. 1997. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:351-369.
22. Hecht, N., et al. 2001. Hyper-IL-6 gene therapy reverses fulminant hepatic failure. Mol. Ther. 3:683-687.